Hemophilia News and Research

RSS
Hemophilia is a rare, inherited bleeding disorder in which your blood doesn’t clot normally. If you have hemophilia, you may bleed for a longer time than others after an injury. You also may bleed internally, especially in your knees, ankles, and elbows. This bleeding can damage your organs or tissues and, sometimes, be fatal.
New guidelines for von Willebrand disease

New guidelines for von Willebrand disease

XYNTHA approved for teatment of hemophilia A by FDA

XYNTHA approved for teatment of hemophilia A by FDA

Transplanted cells can cure hemophilia

Transplanted cells can cure hemophilia

Baxter to develop recombinant Factor IX proteins to treat hemophilia B

Baxter to develop recombinant Factor IX proteins to treat hemophilia B

High-risk individuals less likely to follow through on HIV testing plans

High-risk individuals less likely to follow through on HIV testing plans

FDA approves change in storage conditions for Humate-P

FDA approves change in storage conditions for Humate-P

Irish Government launches program to provide life insurance to people with HIV, Hep C through contaminated blood products

Irish Government launches program to provide life insurance to people with HIV, Hep C through contaminated blood products

Judge acquits Canadian doctors, U.S. drug company in tainted blood case

Judge acquits Canadian doctors, U.S. drug company in tainted blood case

Prophylaxis effective at preventing joint bleeds and preserving joint function and structure in young boys with hemophilia A

Prophylaxis effective at preventing joint bleeds and preserving joint function and structure in young boys with hemophilia A

Xenomics issued European patent for Transrenal Nucleic Acid Technology for Prenatal Diagnostics

Xenomics issued European patent for Transrenal Nucleic Acid Technology for Prenatal Diagnostics

Baxter receives FDA approval for new dosage of Advate for hemophilia A

Baxter receives FDA approval for new dosage of Advate for hemophilia A

Baxter presents findings from the ADAPT study

Baxter presents findings from the ADAPT study

New platform for regulating the expression of therapeutic genes

New platform for regulating the expression of therapeutic genes

FDA approves Norditropin for short stature in children with Noonan syndrome

FDA approves Norditropin for short stature in children with Noonan syndrome

Study finds large number of new proteins implicated in Huntington's disease

Study finds large number of new proteins implicated in Huntington's disease

New treatments for brain hemorrhage

New treatments for brain hemorrhage

FDA approves new treatment for von Willebrand disease

FDA approves new treatment for von Willebrand disease

Muscle restoration in an animal model of Duchenne muscular dystrophy

Muscle restoration in an animal model of Duchenne muscular dystrophy

Scientists tackle cancer with different approaches

Scientists tackle cancer with different approaches

Fragile X and Down syndrome appear to share common genetic cause

Fragile X and Down syndrome appear to share common genetic cause